UNM Cancer Center discovers treatment for deadly disorder


ALBUQUERQUE, N.M. (KRQE) – A new treatment for a deadly immune disorder has been found by researchers at the UNM Comprehensive Cancer Center (UNMCCC).

Mastocytosis, a rare and sometimes deadly immune disorder, is now being treated by a drug called Midostaurin. Midostaurin helps patients with advance Mastocytosis conditions. The most serious type is Leukemia where typically, patients live only about six months after their diagnosis.

Based on a recent clinical trial of Midostaurin, people with advanced Mastocytiosis have lived an average of 28 months longer.

Dr. Tracy George, a researcher at the UNMCCC, and the top American Pathology Expert in Mastocytosis Pathology, joined KRQE’s This Morning team to discuss the study and new drug. Watch above.

The research was recently published in The New England Journal of Medicine, one of the nation’s leading medical journals.

For more information, visit their website.

KRQE.com provides commenting to allow for constructive discussion on the stories we cover. In order to comment here, you acknowledge you have read and agreed to our Terms of Service. Users who violate these terms, including use of vulgar language or racial slurs, will be banned. Please be respectful of the opinions of others. If you see an inappropriate comment, please flag it for our moderators to review.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s